Press Releases | Medtronic

Month Year

Email alerts

Jul 11, 2013

Medtronic Announces New Screw for Market-Leading CD HORIZON® SOLERA® Spinal System

Thomson Reuters ONE via COMTEX) --MEMPHIS, Tenn. - July 11, 2013 - Medtronic, Inc. (NYSE:MDT) today announced the global market introduction of the CD HORIZON® SOLERA® Spinal System Sagittal...
Jun 26, 2013

Medtronic Issues Medical Device Notifications Regarding the SynchroMed® Implantable Infusion System

Thomson Reuters ONE via COMTEX) --FDA Classifies Notifications MINNEAPOLIS - June 26, 2013 - In June 2013, Medtronic, Inc. (NYSE: MDT) initiated four medical device notifications to customers...
Jun 24, 2013

Medtronic Begins Overnight Artifical Pancreas Study

(Thomson Reuters ONE via COMTEX) --Study Marks Critical Milestone Toward Commercialization of a Third-Generation Artificial Pancreas System for People with Diabetes MINNEAPOLIS - June 24, 2013 -...
Jun 24, 2013

Drawer Display of Multiple Assets

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec et risus odio. Vivamus pellentesque, tortor a tempor semper, massa nulla placerat augue, sit amet convallis tellus orci ut massa....
Jun 21, 2013

Medtronic Insulin Pump with Threshold Suspend Reported to Safely Reduce Nocturnal Hypoglycemia Without Increasing A1C

(Thomson Reuters ONE via COMTEX) --ASPIRE In-Home Study Published in New England Journal of Medicine and Presented at American Diabetes Association Annual Scientific Sessions CHICAGO - June 22,...
Jun 20, 2013

Medtronic Increases Its Cash Dividend by 8 Percent; Approves Share Repurchase Plan

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - June 20, 2013 - The board of directors of Medtronic, Inc. (NYSE: MDT) today approved an 8 percent increase in its cash dividend, raising the...
Jun 20, 2013

Medtronic Announces Date for 2013 Annual Meeting

Thomson Reuters ONE via COMTEX) --Shareholders Invited to Attend Annual Meeting on Aug. 22, 2013 MINNEAPOLIS - June 20, 2013 - The board of directors of Medtronic, Inc. (NYSE: MDT), today...
Jun 17, 2013

First-of-Its-Kind Independent Review of INFUSE® Bone Graft Coordinated by Yale University is Complete

Thomson Reuters ONE via COMTEX) --INFUSE Bone Graft Remains Important Treatment Option MINNEAPOLIS - June 17, 2013 - Medtronic, Inc. [NYSE: MDT] acknowledged today the publication of the findings...
Jun 14, 2013

Medtronic Unveils Baseline Data Of Extreme Risk Patients Enrolled In CoreValve® U.S. Pivotal Trial

(Thomson Reuters ONE via COMTEX) --Study Presents Comprehensive Dataset of Patient Characteristics Collected on Extreme Risk TAVR Patients VANCOUVER - June 14, 2013 - Medtronic, Inc. (NYSE: MDT)...
Jun 13, 2013

Medtronic Announces CE Mark of Its ReDuX(TM) Plier Instrument, an Innovative Device to Perform Osteotomies in Spinal Deformity Surgeries

Thomson Reuters ONE via COMTEX) --Novel Disruptive Instrument for Controlled and Progressive Restoration of the Sagittal Imbalance in Patient with Spinal Deformity NICE, France - June 13, 2013 -...
Jun 13, 2013

Medtronic CFO Gary Ellis to Speak at Wells Fargo Healthcare Conference

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - June 13, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Wells Fargo...
Jun 5, 2013

Medtronic to Present at Goldman Sachs Healthcare Conference

(Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - June 5, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 34th Annual...
Jun 4, 2013

Medtronic Nets FDA Clearance and 'CE' Mark for New Peripheral Angioplasty Balloon

Thomson Reuters ONE via COMTEX) --Pacific Plus PTA Catheter Allows for Treatment of Myriad Arteries, from Renal and Iliac to Femoral and Popliteal MINNEAPOLIS -- June 4, 2013 -- Expanding its...
Jun 3, 2013

Medtronic Reaches Major Milestone in Clinical Program for 'IN.PACT Admiral' Drug-Eluting Balloon

Thomson Reuters ONE via COMTEX) --Company Plans to Submit First Module of U.S. Approval Application for Novel Peripheral Angioplasty Device to FDA Over Summer MINNEAPOLIS -- June 3, 2013 --...
May 31, 2013

Endurant AAA Stent Graft Delivers Durable Outcomes for Abdominal Aortic Aneurysm Repair

Thomson Reuters ONE via COMTEX) --Three-Year Clinical Data Presented at Annual Meeting of Society for Vascular Surgery Reaffirms Physician Confidence in Market-Leading Endovascular Device SAN...
May 30, 2013

Medtronic Garners First-Of-Its-Kind FDA Approval for 'AUI' Device with Endurant II AAA Stent Graft System

(Thomson Reuters ONE via COMTEX) --Global Market-Leader in Medical Technology for Endovascular Aortic Repair Also Receives 510(k) Clearance for Sentrant Introducer Sheath MINNEAPOLIS -- May 30,...
May 24, 2013

Medtronic CEO Omar Ishrak to Speak at Sanford Bernstein Strategic Decisions Conference

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - May 24, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Sanford...
May 23, 2013

Medtronic's In.Pact Falcon Drug-Eluting Balloon Yields Positive Outcomes in Small Coronary Arteries

Presented at EuroPCR, One-Year Data from BELLO Study Show Durability of Clinical Results Following Treatment of De Novo Lesions with Novel Angioplasty Device

PARIS -- May 23, 2013 -- One-year data from an Italian multicenter randomized controlled trial of the IN.PACT Falcon drug-eluting balloon from Medtronic, Inc. (NYSE: MDT) demonstrate positive and...
May 23, 2013

Medtronic CoreValve® System Gains First Approval for Transcatheter Valve-In-Valve Procedures

Replacing Degenerated Surgical Valves with CoreValve Results in Significant Hemodynamic Improvements for Patients

MINNEAPOLIS - May 23, 2013 - Medtronic, Inc. (NYSE: MDT) today announced it has received Conformité Européenne (CE) Mark for valve-in-valve (VIV) procedures using the CoreValve® and CoreValve®...
May 23, 2013

Medtronic Completes Enrollment in Landmark U.S. Study of Symplicity(TM) Renal Denervation System for Treatment-Resistant Hypertension

Milestone Marks a Critical Step Forward in Bringing Renal Denervation to Patients in the U.S.

MINNEAPOLIS - May 23, 2013 - Medtronic, Inc. (NYSE: MDT), today announced it has finished randomizing Symplicity HTN-3, the company's pivotal U.S. clinical trial of the Symplicity(TM) renal...
May 21, 2013

Medtronic Finds TAVI with CoreValve® System Cost Effective for Treating Patients with Severe Aortic Stenosis

EuroPCR Presentation of "Real World" ADVANCE Study Confirms Economic Value of Novel Self-Expanding Valve in Patients Unable to Undergo Surgery

PARIS -- May 21, 2013 -- Focused on offering devices that provide both clinical and economic value, Medtronic, Inc. (NYSE: MDT) today unveiled the results of a cost-effectiveness model comparing...
May 21, 2013

Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) System

First Look at Data from Global SYMPLICITY Registry Shows Renal Denervation with the Symplicity(TM) System Meets Performance Expectations in Real-World Setting

MINNEAPOLIS and PARIS - MAY 21, 2013 - Medtronic, Inc. (NYSE: MDT), announced today the first results from the Global SYMPLICITY Registry, which reaffirmed the safety of the renal denervation...
May 21, 2013

Medtronic's Multi-Electrode, Simultaneously Firing Renal Denervation Catheter Shows Reduced Procedure Times While Demonstrating Significant Blood Pressure Reduction

Initial Results from Feasibility Study of the Symplicity Spyral(TM) Catheter Show Safety and Efficacy While More than Halving Mean Procedure Time

MINNEAPOLIS and PARIS - MAY 21, 2013 - Medtronic, Inc. (NYSE: MDT) announced today preliminary results from the feasibility study of its Symplicity SpyralTM multi-electrode, 6 Fr renal denervation...
May 21, 2013

Medtronic CoreValve ADVANCE Study Demonstrates Low Rates of Mortality and Stroke and Sustained Valve Performance

EuroPCR Presentation of One-Year Data from Robust "Real World" Global Study Demonstrates One of the Lowest Mortality Rates among Similar TAVI Studies

PARIS -- May 21, 2013 -- Committed to generating robust clinical data on its CoreValve System for transcatheter aortic valve implantation (TAVI), Medtronic, Inc. (NYSE: MDT) today unveiled for the...
May 21, 2013

Fourth Quarter Caps Solid Year for Medtronic

Q4 Revenue of $4.5 Billion Grew 5% at Constant Currency; 4% as Reported

MINNEAPOLIS - May 21, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2013, which ended April 26, 2013. The Company reported worldwide...

Show per page